US FTC orders Illumina to divest cancer detection test maker Grail

Argentina Noticias Noticias

US FTC orders Illumina to divest cancer detection test maker Grail
Argentina Últimas Noticias,Argentina Titulares
  • 📰 Reuters
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 97%

The U.S. Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.

to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.

Judge Michael Chappell, an administrative law judge at the agency, ruled last year that the $7.1 billion acquisition of Grail would not hurt competition. The FTC staff appealed the decision to agency leadership. The agency has expressed concern that Illumina, the dominant provider of DNA sequencing of tumors and cancer cells that help match patients with the best treatment option, might raise prices or refuse to keep selling to rivals of Grail, which is seeking to market a powerful test to diagnose many kinds of cancer from a single blood test, known as liquid biopsy.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Reuters /  🏆 2. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FTC orders Illumina to divest Grail; Illumina plans to appealFTC orders Illumina to divest Grail; Illumina plans to appealThe Federal Trade Commission on Monday ordered Illumina Inc. to divest Grail Inc., saying that “the deal would stifle competition and innovation in the U.S....
Leer más »

FTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer GrailFTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer GrailThe FTC rejected Illumina’s $7 billion deal for Grail, saying the combination would hurt competition for cancer-detection tests while raising prices
Leer más »

FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer GrailFTC orders Illumina to divest $7.1 billion acquisition of cancer test developer GrailThe decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal.
Leer más »

FTC Integrates With ReserveBlock RBX Network, Unlocks Document Tokenization OpportunitiesFTC Integrates With ReserveBlock RBX Network, Unlocks Document Tokenization OpportunitiesTop-tier research and inspection firm FTC starts using ReserveBlock RBX Network blockchain for data management and verification
Leer más »

High activity spotted at North Korea nuclear complex after Kim's bomb-fuel order, report saysHigh activity spotted at North Korea nuclear complex after Kim's bomb-fuel order, report saysSatellite images show a high level of activity at North Korea's main nuclear site, a U.S. think tank reported on Saturday after the North Korean leader ordered an increase in production of bomb fuel to expand the country's nuclear arsenal.
Leer más »

Star Trek: Starfleet Academy Gets Series Order at Paramount+Star Trek: Starfleet Academy Gets Series Order at Paramount+Paramount+ has officially granted a series order to CBS Studios' upcoming live-action Star Trek: Starfleet Academy.
Leer más »



Render Time: 2025-04-28 04:21:16